Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...
Guanfacine used for treating ADHD in children and adolescents increases corneal aberrations at 6 months but does not affect the retina, choroid, refraction, or optic nerve.
Attention-deficit hyperactivity disorder (ADHD) is a well-known neurodevelopmental disorder that affects the brain's ability to regulate attention and control impulses.